UCI MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $144.5M
- Transactions
- 10,850
- Companies
- 40
- Average per transaction
- $13,313
Who reported the payments
| Merck | $18,255,494 |
| Pfizer | $17,866,184 |
| Genentech, Inc. | $8,490,497 |
| AstraZeneca | $6,768,366 |
| Seagen Inc. | $6,112,261 |
| Eli Lilly | $6,021,499 |
| AbbVie | $5,319,858 |
| Novartis | $4,837,807 |
| Janssen Research & Development, LLC | $4,705,731 |
| Amgen | $3,910,374 |
| Regeneron | $2,403,705 |
| Jazz Pharmaceuticals Inc. | $2,394,222 |
| E.r. Squibb & Sons, L.L.C. | $2,390,437 |
| Medivation LLC. | $2,388,563 |
| Sanofi | $2,372,549 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,181,145 |
| Exelixis Inc. | $1,851,086 |
| Astrazeneca UK Limited | $1,746,880 |
| Gilead | $1,729,925 |
| Eisai Inc. | $1,698,667 |
| Incyte Corporation | $1,637,577 |
| Edwards Lifesciences | $1,258,068 |
| Boston Scientific | $1,148,259 |
| F. Hoffmann-la Roche AG | $1,056,963 |
| Boehringer Ingelheim | $964,105 |
| CSL Behring | $934,924 |
| Pharmacyclics LLC, An Abbvie Company | $931,792 |
| Beigene, Ltd. | $901,267 |
| Amicus Therapeutics, Inc. | $891,161 |
| KARL Storz Endoscopy-america | $874,666 |
| Intuitive Surgical | $841,190 |
| Novo Nordisk AS | $765,911 |
| Cook Incorporated | $747,948 |
| Olympus Corporation Of The Americas | $723,430 |
| Sanofi US Services Inc. | $658,074 |
| Medical Device Business Services, Inc. | $654,035 |
| Canon Medical Systems USA, Inc. | $643,719 |
| Globus Medical | $630,475 |
| Blueprint Medicines Corporation | $629,703 |
| Alcon Research LLC | $627,423 |